Back to Bills
SENATE-BILL 4066119th Congress

SENATE-BILL 4066: S.4066 - Safeguarding Women from Chemical Abortion Act

Introduced: March 11, 2026
Status: Referred to Committee
R.for.R

AI-Powered Summary

Generated by AI Analysis

The 'Safeguarding Women from Chemical Abortion Act' (SENATE-BILL 4066) aims to withdraw federal approval for mifepristone, a medication used for terminating pregnancies, thereby significantly impacting individual access to reproductive healthcare. The legislation introduces a federal tort allowing individuals to sue manufacturers for harm caused by chemical abortion drugs, potentially increasing legal recourse for affected individuals. Major themes include the implications for constitutional rights such as privacy and bodily autonomy, as well as the right to access medical care. Key provisions include the immediate withdrawal of mifepristone's approval 14 days post-enactment and the tort provisions taking effect 90 days after enactment, while ensuring that state laws providing additional remedies are not preempted. The bill raises potential constitutional concerns regarding due process and the risk of excessive litigation, which could deter healthcare providers from offering reproductive services, ultimately affecting the availability of such care for individuals.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill poses significant constitutional challenges, particularly concerning reproductive rights and healthcare access. By targeting mifepristone, it effectively limits individuals' ability to make personal medical decisions, raising serious concerns about privacy and equal protection.

Key Individual Rights Affected

  • Right to Privacy
  • Equal Protection under the Law
  • Due Process Rights

Constitutional Provisions

  • Fourteenth Amendment (Equal Protection Clause)
  • Ninth Amendment (Rights Retained by the People)
  • Due Process Clause of the Fourteenth Amendment

Potential Constitutional Challenges

  • Discrimination against women, particularly those from marginalized communities, could lead to legal challenges under the Equal Protection Clause.
  • The introduction of a federal tort may deter healthcare providers from offering reproductive services, raising due process concerns regarding access to necessary healthcare.

Summary

Senate Bill 4066 significantly impacts individual rights, particularly for women and marginalized groups, by restricting access to reproductive healthcare. The bill raises substantial constitutional concerns regarding privacy, equal protection, and due process, potentially leading to discrimination and reduced healthcare access. The implications extend beyond individual rights, affecting public health outcomes and the broader landscape of reproductive rights in the United States.

Constitutional Analysis

R.for.R

This bill has been analyzed for constitutional compliance using AI-powered analysis of constitutional principles and precedents.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention S. 4066 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Policy Topics

Timeline

March 11, 2026

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat